The Advertising Standards Authority (ASA) has ruled that a dental service based in Turkey was not clear when advertising the services it provides.
The Committee of Advertising Practice (CAP) has introduced a new restriction that prohibits cosmetic interventions advertising being directed at under-18s.
The Advertising Standards Authority (ASA) has issued a ruling against an aesthetic clinic following Whatsapp and Instagram advertisements of prescription-only weight loss injections.
The Committees of Advertising Practice (CAP) has issued an Enforcement Notice following recent reports of education providers not adhering to its advertising rules for promoting training for injectable procedures.
Global pharmaceutical company Allergan has announced key future growth drivers for its medical aesthetics portfolio at its first ever Medical Aesthetics Analyst Day this month.
A clinical study conducted by global pharmaceutical company Allergan suggests that higher doses of Botox Cosmetic (onabotulinumtoxinA) to treat moderate to severe glabella lines produces greater duration of treatment effect.
An Enforcement Notice on January 31 highlighting the rules and concerns around botulinum toxin advertising and other prescription-only medicines on social media has prompted a surge of enquiries to the Advertising Standards Authority (ASA).
The Advertising Standards Authority (ASA) has upheld a complaint against an aesthetic clinic after it issued an advert claiming a facial treatment would ‘eliminate’ dark circles.
Results of a new study indicate that Botox (onabotulinumtoxinA, Allergan) can be used to treat crow’s feet lines safely and effectively.
According to a report published by Fortune Business Insights, the botulinum toxin market will reach US $8,309 million by 2026, exhibiting a compound annual growth rate of 8%.